CLINICAL_TRIALS
trial_result
· 2026-01-07
Clinical Trial Update: Biomarker Predictors of Memantine Sensitivity in Patients With Alzheimer's Disease [Phase 4]
Summary
Phase 4 clinical trial update evaluating biomarker predictors of memantine sensitivity in Alzheimer's disease, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of California, San Diego | Conditions: Alzheimer Disease | Phase 4 | Status: COMPLETED | Results posted: 2026-01-07